DEL BOCCIO, PIERO
 Distribuzione geografica
Continente #
NA - Nord America 3.265
EU - Europa 3.022
AS - Asia 1.455
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 6
SA - Sud America 5
Totale 7.773
Nazione #
US - Stati Uniti d'America 3.248
IT - Italia 804
IE - Irlanda 602
SG - Singapore 525
CN - Cina 497
SE - Svezia 366
UA - Ucraina 343
GB - Regno Unito 299
TR - Turchia 277
FR - Francia 164
DE - Germania 155
IN - India 98
FI - Finlandia 94
RU - Federazione Russa 81
CZ - Repubblica Ceca 34
BE - Belgio 23
VN - Vietnam 22
PL - Polonia 20
CA - Canada 13
AU - Australia 12
AE - Emirati Arabi Uniti 9
NL - Olanda 9
AT - Austria 6
JP - Giappone 6
HK - Hong Kong 5
LT - Lituania 5
ES - Italia 4
EU - Europa 4
KR - Corea 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
GR - Grecia 3
IR - Iran 3
MX - Messico 3
AM - Armenia 2
CL - Cile 2
EG - Egitto 2
IL - Israele 2
KE - Kenya 2
PK - Pakistan 2
ZA - Sudafrica 2
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BR - Brasile 1
CR - Costa Rica 1
HR - Croazia 1
HU - Ungheria 1
LU - Lussemburgo 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 7.773
Città #
Chandler 672
Dublin 594
Singapore 476
Jacksonville 426
Chieti 220
Southend 216
Princeton 199
Izmir 153
Nanjing 143
Dearborn 138
Santa Clara 138
Ashburn 137
Ann Arbor 89
Altamura 88
Beijing 88
Wilmington 88
Boardman 76
Cambridge 64
New York 60
Nanchang 57
Rome 45
Woodbridge 43
Los Angeles 36
Munich 30
Helsinki 29
Kunming 27
Pescara 27
Shenyang 24
Brno 22
Brussels 22
Dong Ket 22
Hangzhou 19
Hebei 18
San Mateo 18
Tianjin 18
Washington 17
Jiaxing 15
Kraków 15
Seattle 15
Augusta 14
Guangzhou 14
L'aquila 13
Grevenbroich 11
London 11
Norwalk 11
Jinan 10
Olomouc 10
Teramo 10
Redwood City 9
Changsha 8
Lappeenranta 8
Milan 8
Pune 8
Sydney 8
Falls Church 7
Frankfurt am Main 7
Leawood 7
Roseto Degli Abruzzi 7
Auburn Hills 6
Bologna 6
Houston 6
L’Aquila 6
Naples 6
Tokyo 6
Vienna 6
Bangalore 5
Dubai 5
Edinburgh 5
Hanover 5
Hong Kong 5
La Spezia 5
San Vito Chietino 5
Toronto 5
Zhengzhou 5
Aquila 4
Brescia 4
Lanzhou 4
Orange 4
Ottawa 4
Pianella 4
Romola 4
San Giovanni 4
Sant'elpidio A Mare 4
Viterbo 4
Alba 3
Ameno 3
Amsterdam 3
Ardabil 3
Bialystok 3
Bitritto 3
Carpi 3
Changchun 3
Chicago 3
Glasgow 3
Hefei 3
Lequile 3
Moscow 3
Ningbo 3
Padova 3
Shanghai 3
Totale 4.940
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 143
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 141
Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis 130
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 125
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 125
Serum Lipidomic study reveals potential early biomarkers for predicting response to chemoradiotherapy in advanced rectal cancer: A pilot study 123
A lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosis. 117
Visible Photostability of Ruthenium and Platinum Phthalocyanines in Water and in the presence of Organic Substrates 112
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes 110
Cleavage of cystatin C is not associated with multiple sclerosis 108
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action 107
Proteomic profiling of coronary thrombus in acute myocardial infarction 107
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 105
Advances in Lipidomics for Cancer Biomarkers Discovery 104
Extracellular vesicles and their potential use in monitoring cancer progression and therapy: The contribution of proteomics 104
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 103
Proteomics characterization of protein adsorption onto hemodialysis membranes 103
Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage 102
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 100
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 100
Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry 98
LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise 97
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 97
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 97
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 96
ESI-MS in the study of the activity of alpha-chymotrypsin in aqueous surfactant media. 95
A proteomic approach for the characterization of C677T mutation of the human gene methylenetetrahydrofolate reductase. 94
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 93
Protein expression profiling of Proteus mirabilis under chemical stress condition: A proteomic investigation without genome 92
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 91
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 91
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 90
Proteomics of thyroid fine-needle apiration: a promising approach for protein biomarker discovery 89
Stereoselective double reduction of 3-methyl-2-cyclohexenone by use of palladium and platinum nanoparticles in tandem with alcohol dehydrogenase 88
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 88
AFFINITY AND SPECIFICITY OF ANTI-GM1 ANTIBODIES IN THE EXPERIMENTAL AXONAL MODEL OF GUILLAIN-BARRE SYNDROME 87
Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite hydroxytyrosol in rat plasma and urine after oral administration. 86
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 86
Neurodegenerative diseases as proteinopathies-driven immune disorders 86
Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin. 86
Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature. 84
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. 83
Homo sapiens proteomics: clinical perspectives 82
Proteomic investigation in the detection of the illicit treatment of calves with growth-promoting agents. 82
Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells. 82
An Italian Innovative Small-Scale Approach to Promote the Conscious Consumption of Healthy Food 82
Transitions of serum albumin in patients with glomerulosclerosis 'in vivo' characterization by electrophoretic titration curves. 81
Quantitative analysis of caffeic acid phenethyl ester in crude propolis by liquid chromatography-electrospray ionization mass spectrometry. 80
Glutathione transferases from Anguilla anguilla liver: identification, cloning and functional characterization. 79
Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy. 79
Characterization of oxidation end product of plasma albumin 'in vivo'. 79
Lo sviluppo di un confronto matematico per analisi differenziali di proteomica: applicazione ai profili MALDI-TOF-MS lineare. 78
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 78
Pre-analytical factors in clinical proteomics investigations: Impact of ex vivo protein modifications for multiple sclerosis biomarker discovery 78
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. 77
Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma 76
Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations. 74
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 74
Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects. 74
Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence 74
Repetitive Fragmentation Products of Albumin and {alpha}1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome. 73
DIFFERENTIAL CEREBRO SPINAL FLUID PROTEOME INVESTIGATION OF LEBER HEREDITARY OPTIC NEUROPATHY (LHON) AND MULTIPLE SCLEROSIS. 73
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 73
Improving protein identification from linear MALDI-TOF spectra: validation of an automated tool for signal denoising and peak identification 72
Monospecific high-affinity and complement activating anti-GM1 antibodies are determinants in experimental axonal neuropathy 72
A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. 72
Proteomic analysis of protein adsorption onto haemodialysis membranes 70
Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms 70
extracellular vescicles as signaling mediators and disease biomarkers across biological barriers 70
High-resolution 2-DE for resolving proteins, protein adducts and complexes in plasma. 69
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 68
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 67
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 64
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 64
Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism 63
Sera mass spectrometry investigation in multiple sclerosis-affected patients 63
Cytotoxic and genotoxic effects of composite resins on cultured human gingival fibroblasts 59
Biomarker investigations in neurodegenerative diseases 57
Ozone effect on the inflammatory and proteomic profile of human macrophages and airway epithelial cells 56
Circulating extracellular vesicles as new inflammation marker in hiv infection 55
Flow Cytometry Analysis of Circulating Extracellular Vesicle Subtypes from Fresh Peripheral Blood Samples 54
Identification of an elongation factor 1Bγ protein with glutathione transferase activity in both yeast and mycelial morphologies from human pathogenic Blastoschizomyces capitatus 50
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 50
Analytical Evaluation of the Ideal Strategy for High-Throughput Flow Injection Analysis by Tandem Mass Spectrometry in Routine Newborn Screening 49
In vitro and in vivo lipidomics as a tool for probiotics evaluation 47
Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials 47
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 46
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 46
Tear proteomics reveals the molecular basis of the efficacy of human recombinant nerve growth factor treatment for Neurotrophic Keratopathy 46
Validation of the GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit Using Dried Blood Samples for High-Throughput Serosurveillance and Standardized Quantitative Measurement of Anti-Spike S1 IgG Antibody Responses Post-Vaccination 46
Targeted metabolomics detects a putatively diagnostic signature in plasma and dried blood spots from head and neck paraganglioma patients 45
Fast LC–MS/MS screening method for the evaluation of drugs, illicit drugs, and other compounds in biological matrices 45
Breast cancer in the era of integrating "Omics" approaches 44
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 43
Proteomics Approach Highlights Early Changes in Human Fibroblasts-Pancreatic Ductal Adenocarcinoma Cells Crosstalk 42
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 42
Multi-omics staging of locally advanced rectal cancer predicts treatment response: a pilot study 41
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 40
Proteomic Investigation of the Role of Nucleostemin in Nucleophosmin-Mutated OCI-AML 3 Cell Line 40
Ozone effect on inflammatory and proteomic profile of human macrophages and airway epithelial cells 40
Totale 7.905
Categoria #
all - tutte 33.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020764 0 0 0 0 82 88 166 97 62 115 119 35
2020/2021717 86 14 97 28 53 127 24 15 109 69 40 55
2021/2022538 6 12 11 88 29 21 12 34 83 30 58 154
2022/20231.874 136 268 117 208 206 352 100 129 240 31 54 33
2023/20241.072 69 56 71 34 42 404 180 45 17 19 6 129
2024/20251.194 136 469 437 80 72 0 0 0 0 0 0 0
Totale 8.281